Runit participates in the Davos Forum for the fourth consecutive year.

Medical AI company Lunit announced on the 20th that it was the first global medical AI company to attend the World Economic Forum (WEF) held in Davos, Switzerland from the 19th to the 23rd for the fourth consecutive year.

The World Economic Forum is an annual event where leading figures in politics, economics, and industry from around the world gather to discuss pressing global issues. This year, marking its 56th anniversary, the forum was held under the theme "A Spirit of Dialogue." Approximately 3,000 government and industry leaders from approximately 130 countries attended the event.

Notably, approximately 65 heads of state and government, including US President Donald Trump, French President Emmanuel Macron, and Canadian Prime Minister Mark Carney, and over 400 political leaders from around the world, participated, setting a record for the largest attendance of government officials ever. The forum focused on the rapid pace of technological innovation and the responsible use of cutting-edge technologies, including artificial intelligence.

Lunit was selected as a "Technology Pioneer" by the World Economic Forum in 2020, and has been invited to the forum every year since its inaugural event. In 2023, it was designated a "Global Innovator," and in 2024, it became the first global medical AI company to achieve "Associate Partner" status. This marks its third year as an Associate Partner.

At this forum, CEO Seo Beom-seok will meet with government health officials from around the world and leaders from the global medical and pharmaceutical industries to discuss the adoption and utilization of AI in the medical field. The forum will explore the role of medical AI in addressing global healthcare challenges, including early cancer detection, treatment decision-making support, and strengthening public health systems.

CEO Seo Beom-seok stated that the reliability of medical AI and securing clinical evidence are emerging as key concerns for governments and medical institutions around the world, and that he plans to reflect expectations and demands for medical AI in his business strategy based on the global network he has accumulated through the Davos Forum.


  • See more related articles